BSE Live
Jan 27, 16:01Prev. Close
442.50
Open Price
442.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:58Prev. Close
440.25
Open Price
445.75
Bid Price (Qty.)
453.50 (90)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 146.88 | 95.59 | 87.41 | 227.90 | 152.54 | |
| Net CashFlow From Operating Activities | 191.32 | 167.63 | 129.31 | 113.41 | 116.03 | |
| Net Cash Used In Investing Activities | -52.52 | -91.28 | -38.99 | -23.57 | -50.23 | |
| Net Cash Used From Financing Activities | -130.42 | -84.81 | -86.18 | -89.41 | -61.56 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 8.38 | -8.46 | 4.14 | 0.43 | 4.24 | |
| Cash And Cash Equivalents Begin of Year | 9.30 | 17.76 | 13.63 | 13.20 | 8.96 | |
| Cash And Cash Equivalents End Of Year | 17.68 | 9.30 | 17.77 | 13.63 | 13.20 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss